Primary Record
IMD-0354
- In stock
- 5,934 g
- Purity
- 99.2 %
- CAS
- 978-62-1
Compound Identifiers & Properties
- CAS
- 978-62-1
- PubChem CID
- 5081913
- SMILES
- C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O
- Canonical SMILES
- O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O
Names & Synonyms
- IMD-0354
- IMD 0354
- 978-62-1
- IKK-2 Inhibitor V
- IKK-2-inhibitor-V
- IMD0354
- N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide
- Kinome_1864
- C15H8ClF6NO2
- RefChem:147935
- TCMDC-125465
- CHILCFMQWMQVAL-UHFFFAOYSA-N
- D0Z5DM
- AC1NO40S
- CHEMBL536151
- N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide
- MFCD00218820
- MLS006011200
- SCHEMBL129165
- DTXSID50243248
- orb1301039
- UNII-76145IS906
- SCHEMBL29406220
- CHEBI:93310
- CTK8G0277
- AOB5931
- DTXCID50165739
- GLXC-06812
- HMS3229F11
- HMS3269F13
- HMS3413J21
- HMS3651D21
- HMS3677J21
- BCP22358
- IMD-2560
- KS-00000T7G
- ZINC3986227
- 2473AH
- BDBM50430160
- EBC-70082
- IMD-0354?
- IMD-2560)
- IN1463
- NSC800773
- NSC816638
- s2864
- 76145IS906
- AKOS017344958
- BCP9000777
- CCG-268447
- CID5081913
- CS-4922
- NSC-800773
- NSC-816638
- SB19541
- SDCCGSBI-0207156.P004
- CID:5081913
- NCGC00165811-01
- NCGC00165811-02
- NCGC00165811-03
- NCGC00165811-06
- NCGC00165811-07
- AC-32886
- AK176084
- AS-71319
- BC600653
- DA-64412
- HY-10172
- SMR004702969
- BCP0726000026
- SID:135653345
- B1587
- IMD-0354, >=98% (HPLC), solid
- SW219746-1
- J2.260.032J
- A12837
- C77350
- Benzamide, N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxy-
- A900175
- C492919
- N-(3,5-Bis-trifluoromethylphenyl)-5-chloro-2-hydroxybenzamide
- N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide
- BRD-K74305673-001-01-3
- BRD-K74305673-001-06-2
- BRD-K74305673-001-07-0
- Q27165022
- 3',5'-Salicyloxylidide, 5-chloro-alpha,alpha,alpha,alpha',alpha',alpha'-hexafluoro-
- B2693-383149
- 5-Chloro-2-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]benzamide
- N-(3,5-Bistrifluoromethylphenyl)-5-Chloro-2-Hydroxybenzamide
- 5-chloro-2-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-benzamide
- Benzamide, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-
- IKK-beta inhibitor (dermatological, atopic dermatitis/acne), IMMD
- IL-6 release inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
- IMD-0354, 99%, a synthetic selective NF-kB inhibitor - 100MG 100mg
- I-kappaB kinase beta inhibitor (oral, rheumatoid arthritis/osteoporosis), IMMD
- 3',5'-SALICYLOXYLIDIDE, 5-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-
- 634914-41-3
- 635-542-2
- I-kappaB kinase beta inhibitor (dermatological, atopic dermatitis/acne), Institute of Medicinal MolecularDesign
- IMD 0354; 5-Chloro-a,a,a,a',a',a'-hexafluoro-3',5'-salicyloxylidide N-(3,5-Bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide